• Cysticercosis Antibody, IgG, CSF
  • Helicobacter pylori and Antibiotic Resistance, Molecular
  • Liver/Kidney Microsome Type 1 Antibodies
  • Rhesus D (Rh D), Typing
  • Mumps Virus Antibody, IgG
  • Glucose-6-Phosphate Dehydrogenase (G6PD)
  • Cardiac Fibrinogen, Plasma
  • Hepatitis C Virus (HCV) by Molecular Method, Qualitative or Quantitative
  • FLT3 (FMS-related Tyrosine Kinase 3) Mutation Analysis, Bone Marrow
  • Bartonella Antibody, IgG and IgM, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
Medical Test

Overview
Access to CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2) is restricted.
Loading...